All screening tools

Free Online Screening

PHQ-9

Patient Health Questionnaire-9

A free, validated screening tool for depression severity. Your answers are scored in your browser — nothing is saved or transmitted.

About this tool

  • The PHQ-9 is a 9-item, free, validated depression screening tool used in clinical practice worldwide.
  • Each item is scored 0-3 (total range 0-27). Higher scores indicate more severe depressive symptoms.
  • Score cutoffs: 0-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.
  • A PHQ-9 score is a SCREENING result, not a diagnosis. A score in any range only suggests further evaluation; only a clinician can diagnose depression.
  • Item 9 (thoughts of self-harm) gets special handling — any non-zero response warrants prompt professional contact regardless of total score.
  • PHQ-9 was developed by Spitzer, Kroenke, and Williams (2001) and is in the public domain — anyone can use it for free.

Take the PHQ-9

Over the last 2 weeks, how often have you been bothered by any of the following problems?

1.Little interest or pleasure in doing things
2.Feeling down, depressed, or hopeless
3.Trouble falling or staying asleep, or sleeping too much
4.Feeling tired or having little energy
5.Poor appetite or overeating
6.Feeling bad about yourself — or that you are a failure or have let yourself or your family down
7.Trouble concentrating on things, such as reading the newspaper or watching television
8.Moving or speaking so slowly that other people could have noticed. Or the opposite — being so fidgety or restless that you have been moving around a lot more than usual
9.Thoughts that you would be better off dead, or of hurting yourself in some way

0 of 9 answered

Your answers are processed in your browser. Nothing is saved or sent to anyone — including Tovani — until you choose to.

Frequently asked

Is this a diagnosis?

No. The PHQ-9 is a screening tool — a structured way to measure symptom severity. A score in any range only suggests whether further evaluation might be helpful. Only a clinician can diagnose depression, which requires a full clinical assessment.

My score is high. What should I do?

For scores in the moderate range or above (10+), professional evaluation is appropriate. Don't wait — depression is treatable, and the available options (therapy, medication, ketamine for treatment-resistant cases) work better when started earlier rather than later. If you have any thoughts of self-harm, contact 988 (Suicide and Crisis Lifeline) immediately, regardless of total score.

Can I take this for someone else?

The PHQ-9 is designed to be self-reported. Filling it out on behalf of another person doesn't produce a valid score because depression involves internal experience the other person can't report on. If you're concerned about someone, encourage them to talk with a clinician directly.

My score is low but I still feel bad. Is something wrong with me?

The PHQ-9 measures depressive symptoms specifically. Distress can come from many sources that don't fit the depression pattern — anxiety, trauma, life circumstances, grief, ADHD, hormonal changes. A low PHQ-9 doesn't mean you're fine; it means the depression-specific symptom pattern isn't strongly present. If something feels wrong, talking with a clinician is still appropriate.

Does the PHQ-9 detect treatment-resistant depression?

Treatment-resistant depression is defined clinically — typically as inadequate response to two or more adequate antidepressant trials. The PHQ-9 alone can't make that determination, but tracking PHQ-9 scores over time during treatment is the most common way clinicians measure whether medication is working. If your PHQ-9 hasn't dropped after 6-8 weeks at a therapeutic dose, that's a clinical signal to consider alternatives.

References

  1. Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT showed 64% response vs 28% placebo in treatment-resistant depression — relevant for the moderately severe to severe PHQ-9 range when conventional treatments have failed. PMID 23982301
  2. Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine's rapid antidepressant effects, including patients with high baseline PHQ-9 scores who haven't responded to first-line treatments. PMID 28249076

Other screening tools